AU Patent

AU7652998A — New cysteine derivatives, processes for their production, and pharmaceuticals containing them

Assigned to Max Planck Gesellschaft zur Foerderung der Wissenschaften eV · Expires 1998-11-27 · 27y expired

What this patent protects

Patent listed against dasiglucagon-hydrochloride.

Drugs covered by this patent

dasiglucagon-hydrochloride (DASIGLUCAGON HYDROCHLORIDE)

Patent Metadata

Patent number: AU7652998A
Jurisdiction: AU
Classification: —
Expires: 1998-11-27
Drug substance claim: No
Drug product claim: No
Assignee: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.